Page 163 - KPJ_2011

* Direct equity holding by the Company is 84 % (2010: 84%).
+ Direct equity holding by the Company is 14 % (2010: 14%).
^ Direct equity holding by the Company is 10% (2010: 10%).
~ Audited by a mrm other than Ernst & Young
16. Interest in subsidiaries (continued)
(a) The following are subsidiaries of the Company (continued):
Point Zone (M) Sdn Bhd ~
Pahang Specialist Hospital Sdn Bhd ~
Skop Yakin (M) Sdn Bhd ~
Healthcare IT Solutions Sdn Bhd ~
Renal-Link Sentosa Sdn Bhd
Sri Kota Refractive And Eye Centre Sdn Bhd ~
Subsidiary of Selangor Specialist
Hospital Sdn Bhd
Hospital Pusrawi SMC Sdn Bhd ~
Subsidiary of PharmaCARE Sdn Bhd
Open Access Sdn Bhd
Subsidiaries of Pharmaserv
Alliances Sdn Bhd
Medical Supplies (Sarawak) Sdn Bhd
Malaysian Institute of Healthcare Management
Sdn Bhd
FP Marketing (S) Pte Ltd ~
Subsidiary of SMC Healthcare Sdn Bhd
Amity Development Sdn Bhd
Malaysia
Malaysia
Malaysia
Malaysia
Malaysia
Malaysia
Malaysia
Malaysia
Malaysia
Malaysia
Singapore
Malaysia
100
100
90
87
100
80
51
100
75
75
100
100
100
100
90
90
100
80
51
100
75
75
100
100
Providing treasury management
To be operating as a specialist hospital
Distribution of general merchandise
/ stationeries
Providing healthcare information
Dormant
Providing medical profession and
consultancy for eye services
Operating as a specialist hospital
Dormant
Distribution of pharmaceutical
products
Dormant
Import, export and distribution
of pharmaceutical, medical and
consumer healthcare products
Dormant
2011 2010
% % Principal activities Name of company
Effective
equity
interest
Country of
incorporation
NOTES TO THE FINANCIAL STATEMENTS
For the financial year ended 31 December 2011 (continued)
ANNUAL REPORT 2011 158